Literature DB >> 25330780

Rheumatoid arthritis: Choline kinase--more than a cancer therapy target?

Nicholas J Bernard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25330780     DOI： 10.1038/nrrheum.2014.180

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Choline kinase inhibition in rheumatoid arthritis.

Authors:  M Guma; E Sanchez-Lopez; A Lodi; R Garcia-Carbonell; S Tiziani; M Karin; J C Lacal; G S Firestein
Journal:  Ann Rheum Dis       Date:  2014-10-01       Impact factor: 19.103
  1 in total
  3 in total

1.  Global metabolic profile identifies choline kinase alpha as a key regulator of glutathione-dependent antioxidant cell defense in ovarian carcinoma.

Authors:  Anna Granata; Roberta Nicoletti; Paola Perego; Egidio Iorio; Balaji Krishnamachary; Fabio Benigni; Alessandro Ricci; Franca Podo; Zaver M Bhujwalla; Silvana Canevari; Marina Bagnoli; Delia Mezzanzanica
Journal:  Oncotarget       Date:  2015-05-10

2.  IL‑1β increases the expression of inflammatory factors in synovial fluid‑derived fibroblast‑like synoviocytes via activation of the NF‑κB‑mediated ERK‑STAT1 signaling pathway.

Authors:  Jie Yang; Junhu Wang; Xiaojun Liang; Hongmou Zhao; Jun Lu; Qiang Ma; Bingfei Jing; Feng Tian
Journal:  Mol Med Rep       Date:  2019-10-21       Impact factor: 2.952

Review 3.  Choline Metabolism Alteration: A Focus on Ovarian Cancer.

Authors:  Marina Bagnoli; Anna Granata; Roberta Nicoletti; Balaji Krishnamachary; Zaver M Bhujwalla; Rossella Canese; Franca Podo; Silvana Canevari; Egidio Iorio; Delia Mezzanzanica
Journal:  Front Oncol       Date:  2016-06-22       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.